Non-Contrast Head CT Features in HIV Patients with and without Antiretrovirals Therapy At Adam Malik General Hospital, Medan
DOI:
https://doi.org/10.32734/jetromi.v7i1.18989Keywords:
HIV, CT-scan, antiretroviral, toxoplasmosis, infectionAbstract
ABSTRACT
Background: Human Immunodeficiency Virus (HIV) weakens the immune system and leads to Acquired Immune Deficiency Syndrome (AIDS). Patients may also developed cerebral toxoplasmosis. CT scans of the head without contrast can help diagnose opportunistic infections and monitor therapy response.
Method: This descriptive, cross-sectional study was conducted from August 2021 to July 2022 at H. Adam Malik General Hospital, Medan. Data is presented in terms of numbers (n) and percentages (%) for variables such as age, gender, and non-contrast head CT scan images. Chi-square tests were used for bivariate analysis, with p-values <0.05 considered significant.
Results: The mean age of patients receiving and not receiving ARVs was 35.0 ± 12.83 years and 37.3 ± 12.5 years, respectively. The majority were male. Most patients on ARVs showed no lesions on CT scans.
Conclusion: Hypodense lesions were the most common findings in patients on ARVs, with multiple lesions observed in the majority of samples.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Journal of Endocrinology, Tropical Medicine, and Infectious Disease (JETROMI)

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Authors submitting a manuscript do so on the understanding that if accepted for publication, copyright of the article shall be assigned to Journal of Endocrinology, Tropical Medicine and Infectious Diseases (JETROMI).
Copyright encompasses exclusive rights to reproduce and deliver the article in all form and media. The reproduction of any part of this journal, its storage in databases and its transmission by any form or media, will be allowed only with a written permission from Journal of Endocrinology, Tropical Medicine and Infectious Diseases (JETROMI).